Iranian Society of Cardiac Surgeons COVID-19 task force version II, restarting elective surgeries.
Alireza Alizadeh GhavidelMohammadreza MirzaaghayanMohammad Ali YousefniaEsmaeil AsdaghpourRamin Baghaei TehraniNaser JalilifarHasan RadmehrMahmoud ShirzadNicholas AustineHosein AhmadiZargham Hossein AhmadiAbbas Afrasiabi RadAhmadali AmirghofranAhmad AminZahra Ansari AvalKamran BabazadehAlireza BakhshandehBahador BaharestaniRezayat ParviziAmirnaser JadbabaeiAlireza JahangirifardSaeed HoseiniManouchehr HekmatAmanollah HeidariMinoosh ShabaniParham SadeghipourMehrdad SalehiShervin Ziabakhsh TabariMohammad AbbasiMaziar Gholampour DahakiAta FirouziMojgan LaaliMohammad Hosein MandegarMohsen MirmohammadsadeghiMohammadali Navvabi ShiraziAkbar NikpajoohPublished in: Journal of cardiovascular and thoracic research (2020)
Given the nature of heart disease and the importance of continuing heart surgery during the pandemic and its aftermath and in order to provide adequate safety for the surgical team and achieve the desired result for patients, as well as the optimal use of ICU beds, the medical team, blood, blood products, and personal protective equipment, it is essential to change the usual approach during the pandemic. There are still a lot of evidences and experiences needed to produce the perfect protocol. Some centers may have a special program for their centers during this period of epidemics that can be respected and performed. Generally, in pandemic conditions, the use of non-surgical approaches is preferred if similar outcomes can be obtained.
Keyphrases
- coronavirus disease
- sars cov
- quality improvement
- end stage renal disease
- palliative care
- respiratory syndrome coronavirus
- randomized controlled trial
- intensive care unit
- ejection fraction
- healthcare
- minimally invasive
- chronic kidney disease
- heart failure
- peritoneal dialysis
- left ventricular
- mental health
- pulmonary hypertension
- prognostic factors
- type diabetes
- metabolic syndrome
- atrial fibrillation